Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab
European Journal of Cancer · 2025-08 · 226 · 115631
DOI: 10.1016/j.ejca.2025.115631 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2025-08. Verfasst von Geun-Ho Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University, Seoul, Re…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Drug Resistance, Neoplasm, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health and Welfare, Ministry of Science and ICT, South Korea, Korea Institute of Science and Technology Information.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea; Division of Hematology-Oncology, Department of Medici…
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Förderung
- Ministry of Health and Welfare
- Ministry of Science and ICT, South Korea
- Korea Institute of Science and Technology Information
- National Research Foundation
- Korea Health Industry Development Institute
- Korea Research Environment Open Network
- Great Southern Development Commission, Government of Western Australia
- Samsung Medical Center, Sungkyunkwan University
Zitieren
APA
Park, G. H., Park, S., Kim, H., Jung, H. A., Sun, J. M., Ahn, J. S., Ahn, M. J., & Lee, S. H. (2025). Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab. European Journal of Cancer, 226, 115631. https://doi.org/10.1016/j.ejca.2025.115631
Vancouver
Park GH, Park S, Kim H, Jung HA, Sun JM, Ahn JS, et al. Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab. European Journal of Cancer. 2025;226:115631. doi:10.1016/j.ejca.2025.115631
BibTeX
@article{Park2025,
author = {Park, Geun-Ho and Park, Sehhoon and Kim, Hyemin and Jung, Hyun-Ae and Sun, Jong-Mu and Ahn, Jin Seok and Ahn, Myung-Ju and Lee, Se-Hoon},
title = {Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab},
journal = {European Journal of Cancer},
year = {2025},
volume = {226},
pages = {115631},
doi = {10.1016/j.ejca.2025.115631}
}
EUVIMED